Two-year effectiveness and safety outcomes in 27,333 edoxaban-treated patients with and without a history of major bleeding from the Global ETNA-AF programme

Bibliografické údaje

Autoři

• doc. RNDr. Ladislav Pecen, CSc.

Rok vydání

2022

Typ publikace

Abstrakt

Periodikum

European Heart Journal

Bibliografická citace

RUSSO, V., WANG, C. C., UNVERDORBEN, M., YAMASHITA, T., PECEN, Ladislav, BORROW, A., CHEN, C., KIRCHHOF, P., DE CATERINA, R. Two-year effectiveness and safety outcomes in 27,333 edoxaban-treated patients with and without a history of major bleeding from the Global ETNA-AF programme. European Heart Journal. 2022, 43(Suppl. 2), 2701-2701. ISSN 0195-668X. E-ISSN 1522-9645
Dostupné z: doi:10.1093/eurheartj/ehac544.2701

DOI

10.1093/eurheartj/ehac544.2701

ID

572206